All News Articles

Showing 1 – 10 (of 555)
group shot of three cancer scientists in a lab at Hollings Cancer Center

Triple Negative Breast Cancer

July 22, 2024

A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer.

Man in white lab coat sits at table in a lab. He's wearing blue gloves and smiling.

Gilliam Fellow

July 16, 2024

Howard Hughes Medical Institute chooses MUSC student, adviser for Gilliam Fellows program based on research, commitment to equity and inclusion.

Illustration with four lightbulbs, one of which is bursting with color, showing an idea.

Women Entrepreneurs

July 12, 2024

The CREW program encourages early-career women in science to become entrepreneurs.

Adam Fox, M.D., pulmonologist and researcher, poses in a hallway at Hollings Cancer Center

Reflex Biomarker Testing

July 01, 2024

Too many lung cancer patients don't get all the biomarker testing they should have before beginning treatment. Dr. Adam Fox wants to change that.

portrait of immunologist Silvia Guglietta in her lab at Hollings Cancer Center

Unlocking Immunotherapy

June 24, 2024

A Hollings immunologist will use an American Cancer Society Research Scholar Grant to study ways to make colorectal cancer more susceptible to immunotherapy.

image of the Hollings Cancer Center building with its preserved 1913 facade of columns and brick

P. gingivalis and Cancer

June 17, 2024

An MUSC Hollings Cancer Center team describes how the bacteria Porphyromonas gingivalis connects to chemotherapy resistance.

Dr. Christina Voelkel-Johnson

Monster Cancer Cells

May 28, 2024

Polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be culprits in disease recurrence after cancer therapy.

 Telestroke demonstration. Nurse Jessica Hewitt (on left), MUSC Health provider Dr. Carlene Kingston (on screen) and nurse Perette Sabatino ( on stretcher).

Optimizing Telestroke

May 22, 2024

External evaluation of MUSC’s telestroke program confirms that stroke center certification and stroke coordinators improve stroke-care metrics.

a nurse leans over a monitor while in the background a patient sits in a chair with a cuff around his arm

Cancer Clinical Trials

May 20, 2024

A new dedicated phase I clinical trials unit at Hollings means more and different types of clinical trials will be available to cancer patients.

Showing 1 – 10 (of 555)